Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04285502
Other study ID # ZEYNEPKAMILHOSPITAL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2020
Est. completion date February 1, 2021

Study information

Verified date February 2020
Source Zeynep Kamil Maternity and Pediatric Research and Training Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This prospective randomized controlled trial was planned to be conducted among total laparoscopic hysterectomies performed at Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital during one year period. The effect of drain insertion during the surgery will be assessed by this clinical trial. Patients will be assigned into two groups as cases and controls. Patients who will a drain inserted will be considered as case group and patients without a drain will be considered as control group. Patients will be evaluated according to their post operative VAS scores, hematocrit levels, their drainage volume and manifestation of an infection after the surgery.


Description:

This prospective randomized controlled trial was planned to be conducted from February 2020 to February 2021 and included total laparoscopic hysterectomies performed at Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital during the study period.

Surgeries on patients with existing comorbidity, with underlying malignant conditions, patients diagnosed deeply infiltrative endometriosis during surgery and patients who undergo multiple surgeries will be excluded from the study.

Clinical and descriptive data will be collected from both paper and electronic records, including the pain of the patient, the need for analgesia at the 6th-12th and 24th hour during the post-operative period. Visual analog scale (VAS) will be used to track the pain progression of the patients. Intraabdominal bleeding will be determined by measuring the hematocrit levels and drainage volume at postoperative day 1. Patients will also be assessed according to manifesting an infection in both the short term and long term.

Patients who will a drain inserted will be considered as case group and patients without a drain will be considered as control group. Data will be analyzed using the Statistical Package for Social Sciences (SPSS). A Chi-squared test will be used to evaluate the significance of the associations between variables. Continuous variables will be displayed as means and standard deviations. A P value of ≤0.050 will be considered as significant.

This study obtained ethical approval from the Medical Research & Ethics Committee of Zeynep Kamil Maternity and Children's Diseases Training and Research Hospital.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date February 1, 2021
Est. primary completion date November 1, 2020
Accepts healthy volunteers No
Gender Female
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- Female

- age between 40-70

- undergoing surgery for a benign condition

- having an abdominal surgery for the first time

Exclusion Criteria:

- existing comorbidity

- with underlying malignant conditions

- patients diagnosed deeply infiltrative endometriosis during surgery

- patients who undergone multiple surgeries

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
SURGICAL DRAIN
A surgical drain is a tube used to remove blood, abscess and any type of fluid at the site of the place it is inserted

Locations

Country Name City State
Turkey Zeynep Kamil Istanbul
Turkey Zeynep Kamil Maternity and Children Training and Research Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Zeynep Kamil Maternity and Pediatric Research and Training Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Weston M, Soyer P, Barral M, Dohan A, Pierre S, Rabei R, Garcia-Reyes K, Kohi MP. Role of Interventional Procedures in Obstetrics and Gynecology. Radiol Clin North Am. 2020 Mar;58(2):445-462. doi: 10.1016/j.rcl.2019.11.006. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary analgesia need at the post-operative period patient need for analgesia during post operative first day post operative 6. hour
Primary hematocrit levels patient hematocrit level at post operative day 1 post operative first day
Primary drainage volume drainage volume at postoperative day post operative first day
Primary post operative infection manifesting an post operative infection in short term and long term post operative first day and post operative 1. week
Primary pain post operative 6.-12. and 24. hour will be measured using VAS score pain
Secondary analgesia need at the post-operative 6. hour patient need for analgesia post-operative 6. hour
Secondary analgesia need at the post-operative 12. hour patient need for analgesia post-operative 12. hour
See also
  Status Clinical Trial Phase
Not yet recruiting NCT00484835 - Are Sutures Required in Total Abdominal Hysterectomy? A Randomised Control Trial Phase 1
Withdrawn NCT02543385 - S Ketamine Use in Total Abdominal Hysterectomy N/A